Clinical Trial: Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188428) titled 'Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment' on Sept. 16.

Brief Summary: The aim of this study was to evaluate the real-world treatment patterns, healthcare resource use and costs among patients newly diagnosed with CML who were treated with tyrosine kinase inhibitors (TKIs) in first- and second-line therapy.

Study Start Date: Feb. 27, 2024

Study Type: OBSERVATIONAL

Condition: Leukemia, Chronic Myeloid

Recruitment Status: COMPLETED

Sponsor: Novartis Pharmaceuticals

Published by HT Digital Content Services with permission from Health Daily Digest....